APOBEC3B and cancer: The association of the APOBEC3B deletion with cancer has been analyzed within eleven case-control studies conducted in populations of different ethnicities, different cancer types and different sizes [published and available in PubMed up to February 2017 [17, 25, 31, 32, 34, 36–41].